Bo Zhang

14.9k total citations
304 papers, 7.5k citations indexed

About

Bo Zhang is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Bo Zhang has authored 304 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Public Health, Environmental and Occupational Health, 98 papers in Infectious Diseases and 86 papers in Molecular Biology. Recurrent topics in Bo Zhang's work include Mosquito-borne diseases and control (100 papers), Viral Infections and Vectors (64 papers) and HIV Research and Treatment (24 papers). Bo Zhang is often cited by papers focused on Mosquito-borne diseases and control (100 papers), Viral Infections and Vectors (64 papers) and HIV Research and Treatment (24 papers). Bo Zhang collaborates with scholars based in China, United States and Singapore. Bo Zhang's co-authors include Pei‐Yong Shi, Zhiming Yuan, Hongping Dong, Robyn S. Klein, Han‐Qing Ye, Michael Diamond, Cheng‐Lin Deng, Qiu‐Yan Zhang, Cheng-Lin Deng and Peng Gong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Advanced Materials.

In The Last Decade

Bo Zhang

295 papers receiving 7.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Zhang China 49 2.6k 2.6k 2.4k 1.2k 734 304 7.5k
Wei Zhang China 47 3.5k 1.4× 3.1k 1.2× 3.3k 1.4× 1.3k 1.1× 1.8k 2.5× 309 10.2k
Hsiao‐Sheng Liu Taiwan 56 3.6k 1.4× 3.7k 1.5× 3.3k 1.4× 1.1k 1.0× 1.9k 2.5× 296 10.4k
Étienne Decroly France 47 5.3k 2.1× 1.1k 0.4× 2.9k 1.2× 1.0k 0.9× 998 1.4× 126 8.7k
Duncan R. Smith Thailand 45 2.1k 0.8× 2.8k 1.1× 1.6k 0.7× 693 0.6× 841 1.1× 243 6.7k
Rong Zhang China 39 1.9k 0.7× 915 0.4× 2.2k 0.9× 1.0k 0.9× 692 0.9× 219 6.2k
Yi Shi China 50 4.1k 1.6× 1.5k 0.6× 2.8k 1.2× 1.5k 1.3× 3.4k 4.6× 199 9.8k
Anirban Basu India 49 1.7k 0.7× 2.2k 0.9× 2.2k 0.9× 1.7k 1.4× 728 1.0× 186 7.4k
Yee-Shin Lin Taiwan 53 3.4k 1.3× 4.1k 1.6× 2.0k 0.8× 1.4k 1.2× 1.2k 1.7× 168 7.9k
Andrea T. Da Poian Brazil 39 1.5k 0.6× 1.8k 0.7× 1.4k 0.6× 565 0.5× 571 0.8× 103 4.2k
Hiroshi Suzuki Japan 46 1.3k 0.5× 1.3k 0.5× 1.6k 0.7× 1.6k 1.4× 888 1.2× 279 7.6k

Countries citing papers authored by Bo Zhang

Since Specialization
Citations

This map shows the geographic impact of Bo Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Zhang more than expected).

Fields of papers citing papers by Bo Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Zhang. The network helps show where Bo Zhang may publish in the future.

Co-authorship network of co-authors of Bo Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Zhang. A scholar is included among the top collaborators of Bo Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Zhang. Bo Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Qianqian, Bo Zhang, Yaling Zhai, et al.. (2025). The role of innate lymphoid cells in kidney disease. Cytokine & Growth Factor Reviews. 85. 146–157.
2.
Li, Jinwen, Hongyan Han, Peng Feng, et al.. (2025). Transitioning from molecular methods to therapeutic methods: An in‑depth analysis of glioblastoma (Review). Oncology Reports. 53(4). 1–17. 2 indexed citations
3.
Moraes, Fábio Rogério de, José González, Cíntia Bittar, et al.. (2025). In Vitro Evaluation of the Antiviral Activity of Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) Against Mayaro Virus. Viruses. 17(2). 258–258. 2 indexed citations
4.
Liu, Huiwen, Bo Zhang, Honglan Wang, et al.. (2024). Targeted Delivery of c(RGDfk)‐Modified Liposomes to Bone Marrow Through In Vivo Hitchhiking Neutrophils for Multiple Myeloma Therapy. Advanced Science. 12(12). e2409895–e2409895. 2 indexed citations
5.
Zhang, Qiu‐Yan, Hongqing Zhang, Yanan Zhang, et al.. (2023). Newcastle Disease Virus (NDV)-based vaccine candidate against SARS-CoV-2 Omicron by intranasal immunization. Antiviral Research. 220. 105757–105757. 4 indexed citations
6.
Pan, Tao, Huijie Fan, Xu Wang, et al.. (2022). Neuroprotective effect of hyperoside in MPP+/MPTP -induced dopaminergic neurodegeneration. Metabolic Brain Disease. 38(3). 1035–1050. 11 indexed citations
7.
Li, Jiaqi, Zherui Zhang, Hongqing Zhang, et al.. (2021). Intranasal delivery of replicating mRNA encoding neutralizing antibody against SARS-CoV-2 infection in mice. Signal Transduction and Targeted Therapy. 6(1). 369–369. 24 indexed citations
8.
Xu, Aoshuang, Jiasi Zhang, Liping Zuo, et al.. (2021). FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m6A-YTHDF2-dependent manner. Molecular Therapy. 30(3). 1104–1118. 50 indexed citations
9.
Wang, Yong, Yan Chen, Yijie Wang, et al.. (2020). ZMYND8 Expression in Breast Cancer Cells Blocks T-Lymphocyte Surveillance to Promote Tumor Growth. Cancer Research. 81(1). 174–186. 15 indexed citations
10.
Ma, Fuying, Zherui Zhang, Mingxin Li, et al.. (2020). Vaccination with Consensus H7 Elicits Broadly Reactive and Protective Antibodies against Eurasian and North American Lineage H7 Viruses. Vaccines. 8(1). 143–143. 5 indexed citations
11.
Zhang, Ying, Shaobo Wang, Yinghui Huang, et al.. (2019). Inhibition of CYP1B1 ameliorates cardiac hypertrophy induced by uremic toxin. Molecular Medicine Reports. 21(1). 393–404. 14 indexed citations
12.
Shan, Chao, Xuping Xie, Jing Zou, et al.. (2018). Using a Virion Assembly-Defective Dengue Virus as a Vaccine Approach. Journal of Virology. 92(21). 16 indexed citations
13.
Zhang, Bo, et al.. (2016). Zika virus: a flavivirus caused pandemics in Latin America. Virologica Sinica. 31(2). 101–102. 3 indexed citations
14.
Ma, Yunyun, Lin Sun, Xiujuan Chen, et al.. (2016). Vinpocetine Attenuates the Osteoblastic Differentiation of Vascular Smooth Muscle Cells. PLoS ONE. 11(9). e0162295–e0162295. 8 indexed citations
15.
Wang, Hongju, Siqing Liu, Bo Zhang, & Wenqiang Wei. (2016). Analysis of Synonymous Codon Usage Bias of Zika Virus and Its Adaption to the Hosts. PLoS ONE. 11(11). e0166260–e0166260. 74 indexed citations
16.
Deng, Cheng‐Lin, et al.. (2015). Identifying the pattern of molecular evolution for Zaire ebolavirus in the 2014 outbreak in West Africa. Infection Genetics and Evolution. 32. 51–59. 14 indexed citations
17.
Zhang, Bo, Mercy M. Davidson, Hongning Zhou, et al.. (2013). Cytoplasmic Irradiation Results in Mitochondrial Dysfunction and DRP1-Dependent Mitochondrial Fission. Cancer Research. 73(22). 6700–6710. 80 indexed citations
18.
McCandless, Erin E., Bo Zhang, Michael Diamond, & Robyn S. Klein. (2008). CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis. Proceedings of the National Academy of Sciences. 105(32). 11270–11275. 105 indexed citations
19.
Klein, Robyn S., Eugene C. Lin, Bo Zhang, et al.. (2005). Neuronal CXCL10 Directs CD8 + T-Cell Recruitment and Control of West Nile Virus Encephalitis. Journal of Virology. 79(17). 11457–11466. 337 indexed citations
20.
Zhang, Bo, et al.. (2004). Development of Single-Domain Recombinant Antibodies to Reverse Transcriptase Domain of Human hTERT. PubMed. 23(4). 244–249. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026